Inventor
PATEL DINESH V
US53 patents
⚠️ This page may combine multiple inventors who share the name “PATEL DINESH V”. Patents are grouped by organization below to help distinguish them — per-person disambiguation is on the roadmap.
PROTAGONIST THERAPEUTICS INC
17 patentsUS9518091B2Dec 13, 2016
A4B7 peptide monomer and dimer antagonists
PROTAGONIST THERAPEUTICS INC34 citations98
US9624268B2Apr 18, 2017
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
PROTAGONIST THERAPEUTICS INC40 citations97
US10941183B2Mar 9, 2021
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
PROTAGONIST THERAPEUTICS INC13 citations94
US10626146B2Apr 21, 2020
α4β7 thioether peptide dimer antagonists
PROTAGONIST THERAPEUTICS INC15 citations94
US10059744B2Aug 28, 2018
α4β7 thioether peptide dimer antagonists
PROTAGONIST THERAPEUTICS INC22 citations94
US9809623B2Nov 7, 2017
α4β7 peptide monomer and dimer antagonists
PROTAGONIST THERAPEUTICS INC26 citations94
US9714270B2Jul 25, 2017
a4B7 integrin thioether peptide antagonists
PROTAGONIST THERAPEUTICS INC27 citations94
US9273093B2Mar 1, 2016
α4β7 peptide dimer antagonists
PROTAGONIST THERAPEUTICS INC31 citations94
US10196424B2Feb 5, 2019
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
PROTAGONIST THERAPEUTICS INC26 citations93
US10035824B2Jul 31, 2018
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
PROTAGONIST THERAPEUTICS INC24 citations93
US10023614B2Jul 17, 2018
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
PROTAGONIST THERAPEUTICS INC23 citations93
US11111272B2Sep 7, 2021
α4α7 peptide monomer and dimer antagonists
PROTAGONIST THERAPEUTICS INC10 citations86
US10787490B2Sep 29, 2020
Peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory diseases
PROTAGONIST THERAPEUTICS INC18 citations85
US10301371B2May 28, 2019
Cyclic monomer and dimer peptides having integrin antagonist activity
PROTAGONIST THERAPEUTICS INC19 citations85
US10407468B2Sep 10, 2019
Methods for synthesizing α4β7 peptide antagonists
PROTAGONIST THERAPEUTICS INC13 citations82
US11840581B2Dec 12, 2023
α4β7 thioether peptide dimer antagonists
PROTAGONIST THERAPEUTICS INC1 citations73
US11884748B2Jan 30, 2024
Oral peptide inhibitors of interleukin-23 receptor and their use to treat inflammatory bowel diseases
PROTAGONIST THERAPEUTICS INC0 citations62
UPJOHN CO
8 patentsUS6239152B1May 29, 2001
Oxazolidinone combinatorial libraries, compositions and methods of preparation
UPJOHN CO83 citations97
US6869965B2Mar 22, 2005
Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
UPJOHN CO27 citations92
US6689769B2Feb 10, 2004
Antimicrobial quinolone derivatives and use of the same to treat bacterial infections
UPJOHN CO36 citations92
US6562844B2May 13, 2003
Oxazolidinone combinatorial libraries, compositions and methods of preparation
UPJOHN CO23 citations92
US6531470B1Mar 11, 2003
Oxazolidinone combinatorial libraries, compositions and methods of preparation
UPJOHN CO36 citations92
US6441005B1Aug 27, 2002
Oxazolidinone compounds and compositions, and methods of using the same
UPJOHN CO27 citations92
US7002020B1Feb 21, 2006
Oxazolidinone combinatorial libraries, compositions and methods of preparation
UPJOHN CO2 citations62
US6743811B2Jun 1, 2004
Oxazalidinone compounds and methods of preparation and use thereof
UPJOHN CO0 citations52
AFFYMAX TECH NV
6 patentsUS5932579AAug 3, 1999
Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
AFFYMAX TECH NV97 citations97
US5990112ANov 23, 1999
Inhibitors of metalloproteases pharmaceutical compositions comprising same and methods of their use
AFFYMAX TECH NV73 citations96
US5840698ANov 24, 1998
Inhibitors of collagenase-1 and stormelysin-I metalloproteases, pharmaceutical compositions comprising same and methods of their use
AFFYMAX TECH NV37 citations92
US5929278AJul 27, 1999
Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
AFFYMAX TECH NV12 citations74
US5831004ANov 3, 1998
Inhibitors of metalloproteases, pharmaceutical compositions comprising same and methods of their use
AFFYMAX TECH NV13 citations74
US6271232B1Aug 7, 2001
Collagenase-1 and stromelysin-1 inhibitors, pharmaceutical compositions comprising same and methods of their use
AFFYMAX TECH NV5 citations62
VERSICOR INC
5 patentsUS6025371AFeb 15, 2000
Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
VERSICOR INC57 citations96
US6281245B1Aug 28, 2001
Methods for solid-phase synthesis of hydroxylamine compounds and derivatives, and combinatorial libraries thereof
VERSICOR INC28 citations92
US6448058B1Sep 10, 2002
Methods for solid phase synthesis of mercapto compounds and derivatives, combinatorial libraries thereof and compositions obtained thereby
VERSICOR INC10 citations73
US6413724B1Jul 2, 2002
Solid phase and combinatorial library syntheses of fused 2,4-pyrimidinediones
VERSICOR INC7 citations73
US6541276B2Apr 1, 2003
Methods for solid-phase synthesis of hydroxylamine compounds and derivatives and combinatorial libraries thereof
VERSICOR INC5 citations62
VICURON PHARM INC
3 patentsUS6987104B2Jan 17, 2006
Pyrrolidine bicyclic compounds and its derivatives, compositions and methods of use
VICURON PHARM INC12 citations83
US7199105B2Apr 3, 2007
Lincomycin derivatives possessing antibacterial activity
VICURON PHARM INC8 citations73
US7164011B2Jan 16, 2007
Lincomycin derivatives possessing antibacterial activity
VICURON PHARM INC8 citations73
SQUIBB & SONS INC
2 patentsMIIKANA THERAPEUTICS INC
2 patentsBRISTOL MYERS SQUIBB CO
1 patentBRISTOL MEYERS SQUIBB CO
1 patentMIIKANA THERAPEUTICS
1 patentNOVARTIS AG
1 patentPFIZER
1 patent(unassigned)
1 patentXIAO XIAO-YI
1 patentShowing the top 50 of 53 patents by PatentIndex Score.